Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir (Q34726282)

4 August 2017

1 reference

title

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir (English)

1 reference

4 August 2017

6

Carlo Federico Perno

1 reference

4 August 2017

3

Jan Balzarini

1 reference

4 August 2017

Stefano Aquaro

1

1 reference

4 August 2017

Raffaele Caliò

series ordinal

2

1 reference

4 August 2017

Maria Concetta Bellocchi

series ordinal

4

1 reference

4 August 2017

Enrico Garaci

series ordinal

5

1 reference

4 August 2017

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

55

1 reference

4 August 2017

2

1 reference

4 August 2017

209-225

1 reference

Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate: efficient intracellular delivery of d4TMP

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

The challenge of viral reservoirs in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Latent reservoirs of HIV: obstacles to the eradication of virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Viral dynamics in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

New drug combinations for the treatment of murine AIDS and macrophage protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Intracellular GSH content and HIV replication in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Electron microscopic observation of the aggregation of membrane proteins in human erythrocyte by melittin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Oligomeric structure and the anion transport function of human erythrocyte band 3 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Reduction in hospitalization costs, morbidity, disability, and mortality in patients with aids treated with protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Structured treatment interruptions for the management of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Structures of human genes coding for cytokine LD78 and their expression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

A cDNA clone used to study mRNA inducible in human tonsillar lymphocytes by a tumor promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Macrophages as a source of HIV during opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Glutathione inhibits HIV replication by acting at late stages of the virus life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE)phosphotriester and 3'-azido-2',3'-dideoxythymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency metabolism and activity against human immunodeficiency virus or herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Epidermal Langerhans cells--a target for HTLV-III/LAV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

A model of human immunodeficiency virus encephalitis in scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900052-9

7 January 2021

10.1016/S0166-3542(02)00052-9

Identifiers

DOI

1 reference

4 August 2017

1 reference